Published in Beilstein J Nanotechnol on January 09, 2015
In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles. Chem Soc Rev (2015) 0.92
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles. Int J Mol Sci (2015) 0.80
The Effect of Superparamagnetic Iron Oxide Nanoparticle Surface Charge on Antigen Cross-Presentation. Nanoscale Res Lett (2017) 0.76
Quantum dots for live cells, in vivo imaging, and diagnostics. Science (2005) 21.62
Semiconductor nanocrystals as fluorescent biological labels. Science (1998) 16.68
A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect (2006) 6.66
Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc (2011) 3.19
Mammalian zinc transporters. Annu Rev Nutr (2004) 2.82
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Synthesis of monodisperse iron oxide nanocrystals by thermal decomposition of iron carboxylate salts. Chem Commun (Camb) (2004) 2.24
Long-term exposure to CdTe quantum dots causes functional impairments in live cells. Langmuir (2007) 2.09
In vivo quantum-dot toxicity assessment. Small (2010) 1.78
Core/Shell semiconductor nanocrystals. Small (2009) 1.68
Persistent tissue kinetics and redistribution of nanoparticles, quantum dot 705, in mice: ICP-MS quantitative assessment. Environ Health Perspect (2007) 1.61
Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat Nanotechnol (2009) 1.47
Zinc: a multipurpose trace element. Arch Toxicol (2005) 1.45
Observation of discrete electronic states in a zero-dimensional semiconductor nanostructure. Phys Rev Lett (1988) 1.44
Cadmium-containing nanoparticles: perspectives on pharmacology and toxicology of quantum dots. Toxicol Appl Pharmacol (2009) 1.31
The biochemistry of chromium. J Nutr (2000) 1.29
Nanotoxicity assessment of quantum dots: from cellular to primate studies. Chem Soc Rev (2013) 1.22
The cytotoxicity of cadmium-based quantum dots. Biomaterials (2011) 1.19
Interactions between cadmium and zinc in the organism. Food Chem Toxicol (2001) 1.18
Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins. Biometals (2011) 1.12
Quantum dot cytotoxicity and ways to reduce it. Acc Chem Res (2012) 1.12
Are quantum dots toxic? Exploring the discrepancy between cell culture and animal studies. Acc Chem Res (2012) 1.07
Toxicity of nanocrystal quantum dots: the relevance of surface modifications. Arch Toxicol (2011) 1.02
Synthesis and characterization of intrinsically radiolabeled quantum dots for bimodal detection. Am J Nucl Med Mol Imaging (2012) 0.98
Mammalian iron transporters: families SLC11 and SLC40. Mol Aspects Med (2013) 0.96
A simple and widely applicable method to 59Fe-radiolabel monodisperse superparamagnetic iron oxide nanoparticles for in vivo quantification studies. ACS Nano (2012) 0.93
Iron oxide based MR contrast agents: from chemistry to cell labeling. Curr Med Chem (2009) 0.93
In vivo distribution, pharmacokinetics, and toxicity of aqueous synthesized cadmium-containing quantum dots. Biomaterials (2011) 0.92
Development of a compartmental model of human zinc metabolism: identifiability and multiple studies analyses. Am J Physiol Regul Integr Comp Physiol (2000) 0.91
Semicondutor quantum dots-based metal ion probes. Nanoscale (2013) 0.86
New insights into the molecular mechanism of intestinal fatty acid absorption. Eur J Clin Invest (2013) 0.85
Organ distribution of quantum dots after intraperitoneal administration, with special reference to area-specific distribution in the brain. Nanotechnology (2010) 0.85
Performance parameters of the Hamburg 4 pi whole body radioactivity detector. Phys Med Biol (1977) 0.84
Quantum dot-based nanoprobes for in vivo targeted imaging. Curr Mol Med (2013) 0.83
Development of a compartmental model of zinc kinetics in mice. J Nutr (2008) 0.83
Autoradiographic studies on the distribution of zinc-65 in mice. J Nutr (1968) 0.83
Essential Elements to Consider for MRI Cell Tracking Studies with Iron Oxide-based Labeling Agents. J Basic Clin Med (2012) 0.82
Low-molecular-weight chromium-binding substance from chicken liver and American alligator liver. Comp Biochem Physiol B Biochem Mol Biol (2006) 0.81
Bioavailability of chromium(III)-supplements in rats and humans. Biometals (2012) 0.80
Cytotoxicity of cadmium-containing quantum dots based on a study using a microfluidic chip. Nanotechnology (2012) 0.79
The cell-type specific uptake of polymer-coated or micelle-embedded QDs and SPIOs does not provoke an acute pro-inflammatory response in the liver. Beilstein J Nanotechnol (2014) 0.79
In vivo monitoring of distributional transport kinetics and extravasation of quantum dots in living rat liver. Nanotechnology (2013) 0.77
Absorption, excretion and retention of 51Cr from labelled Cr-(III)-picolinate in rats. Biometals (2008) 0.77
Thermogenic adipocytes promote HDL turnover and reverse cholesterol transport. Nat Commun (2017) 0.78
The fate of a designed protein corona on nanoparticles in vitro and in vivo. Beilstein J Nanotechnol (2015) 0.75